scanX
Home
Granules

Granules

527.05
-4.40
(-0.83%)
Market Cap
12,780.63 Cr
EPS
16.73
PE Ratio
26.91
Dividend Yield
0.28 %
Industry
Healthcare
52 Week High
721.00
52 Week low
389.35
PB Ratio
3.76
Debt to Equity
0.40
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
 1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
Divis Laboratories
 5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
Cipla
 1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
Torrent Pharmaceuticals
 3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
Dr Reddys Laboratories
 1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
Mankind Pharma
 2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
Zydus Life Science
 899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
Lupin
 1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
Aurobindo Pharma
 1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
Abbott
 29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
-0.33 %
Net Income Growth
-21.54 %
Cash Flow Change
-40.52 %
ROE
-31.01 %
ROCE
-21.01 %
EBITDA Margin (Avg.)
-6.98 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
357
324
354
326
372
347
362
357
356
382
404
417
517
483
598
640
634
623
708
708
682
741
861
861
803
858
893
1,002
1,034
1,024
1,156
1,147
1,199
984
1,190
1,150
1,171
1,171
960
1,139
Expenses
306
260
284
260
292
275
284
277
278
302
316
337
460
381
480
519
516
477
556
573
500
552
602
633
597
648
737
823
837
808
908
915
967
849
977
905
920
921
763
907
EBITDA
51
64
69
67
81
72
78
81
79
80
89
80
57
102
118
121
119
146
152
135
182
189
260
228
205
209
156
179
197
216
248
232
232
135
213
245
251
251
197
232
Operating Profit %
14 %
19 %
19 %
20 %
21 %
20 %
21 %
22 %
22 %
20 %
20 %
18 %
9 %
16 %
17 %
18 %
16 %
20 %
21 %
19 %
17 %
25 %
30 %
25 %
25 %
24 %
17 %
17 %
19 %
21 %
21 %
20 %
19 %
14 %
18 %
21 %
21 %
21 %
20 %
20 %
Depreciation
14
14
14
15
15
16
19
19
18
18
19
20
20
25
27
27
27
29
30
39
39
34
36
37
45
39
40
39
40
43
44
48
49
49
53
52
53
53
53
57
Interest
8
8
9
10
9
8
8
8
8
8
10
8
6
7
8
8
7
7
7
7
7
6
6
7
7
7
6
5
6
7
13
17
19
23
26
29
29
27
26
27
Profit Before Tax
29
42
46
42
56
47
51
54
53
55
60
52
30
71
84
87
84
110
115
89
137
149
217
184
154
163
110
135
150
166
190
167
164
66
136
170
176
181
128
153
Tax
7
14
14
13
23
8
11
15
7
18
19
17
10
19
23
27
20
27
19
25
44
38
54
37
26
43
30
34
39
38
45
43
44
18
34
45
46
47
31
35
Net Profit
22
29
32
29
33
39
41
39
46
37
40
35
20
52
60
60
64
83
96
64
92
111
164
147
128
120
81
101
111
128
145
124
120
48
102
126
130
135
97
118
EPS in ₹
1.10
1.40
1.58
1.42
1.60
1.80
1.88
1.79
2.09
1.61
1.76
1.38
0.81
2.04
2.37
2.37
2.52
3.27
3.77
2.52
3.63
4.39
6.60
5.92
5.15
4.85
3.26
4.07
4.48
5.14
5.85
5.11
4.94
1.98
4.22
5.18
5.35
5.56
4.01
4.85
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,203
1,563
1,879
2,677
2,983
3,228
3,714
4,513
4,905
5,521
Fixed Assets
617
560
644
777
944
1,204
1,332
1,541
1,911
2,096
Current Assets
500
818
828
1,187
1,282
1,629
1,997
2,505
2,574
2,905
Capital Work in Progress
62
77
267
515
496
294
239
356
239
272
Investments
0
70
108
157
210
19
19
20
21
22
Other Assets
524
856
859
1,229
1,332
1,711
2,123
2,596
2,733
3,132
Total Liabilities
1,203
1,563
1,879
2,677
2,983
3,228
3,714
4,513
4,905
5,521
Current Liabilities
415
655
787
878
897
893
1,173
1,642
1,814
2,082
Non Current Liabilities
357
247
188
495
557
491
367
284
256
213
Total Equity
431
662
904
1,304
1,530
1,844
2,173
2,587
2,835
3,226
Reserve & Surplus
411
613
881
1,279
1,504
1,818
2,149
2,562
2,811
3,201
Share Capital
20
22
23
25
25
25
25
25
24
24
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
24
75
-82
66
-25
103
-144
143
107
90
Investing Activities
-146
-162
-326
-462
-270
-160
-277
-379
-192
-358
Operating Activities
150
151
188
-1
262
476
433
332
739
439
Financing Activities
19
86
56
529
-17
-213
-299
190
-440
8
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Oct 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
42.04 %
42.04 %
42.04 %
41.98 %
41.98 %
41.98 %
41.93 %
42.02 %
42.02 %
42.02 %
42.02 %
41.96 %
41.96 %
41.96 %
38.87 %
38.87 %
38.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
19.57 %
20.39 %
19.49 %
15.87 %
DIIs
1.50 %
2.86 %
2.77 %
4.34 %
3.97 %
3.03 %
4.32 %
4.23 %
4.76 %
5.03 %
6.68 %
6.85 %
10.14 %
10.70 %
14.12 %
14.86 %
19.57 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.21 %
29.74 %
27.00 %
24.99 %
24.55 %
25.26 %
21.72 %
21.60 %
20.74 %
21.13 %
21.91 %
21.11 %
20.39 %
19.38 %
18.78 %
18.29 %
17.45 %
Others
30.26 %
25.36 %
28.19 %
28.69 %
29.49 %
29.73 %
32.03 %
32.15 %
32.49 %
31.82 %
29.39 %
30.07 %
27.51 %
8.39 %
7.84 %
8.49 %
8.27 %
No of Share Holders
0
1,93,871
2,61,165
2,39,520
2,16,385
2,10,785
2,14,539
2,16,055
2,02,329
1,90,894
2,01,054
2,07,055
1,90,691
1,82,142
1,79,870
2,02,198
1,77,554

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.9 1 1 1 1.5 1.5 1.5 1.5 0.00
Dividend Yield (%) 0.00 0.87 0.87 0.7 0.33 0.49 0.52 0.35 0.28 0.00

Corporate Action

Technical Indicators

Bearish
0
Neutral
0
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Technical Screeners
Candlestick Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.